Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.

Latest updates to the Cardiol Therapeutics Press Releases page
- Check2 days agoChange DetectedStock price values on the investor page were updated (new $1.37 and $1.87; old $1.30 and $1.78 removed). A new press release entry about a Fireside Chat was added to the press releases list, and an older milestone release was deleted.SummaryDifference1%

- Check9 days agoChange DetectedA MAVERIC Phase II results press release entry was added (May 7, 2026) and an ARCHER release from December 1, 2025 was removed. The left stock-price panel updated from $1.355 and $1.84 to $1.30 and $1.78.SummaryDifference1%

- Check16 days agoChange DetectedAdded a new press release entry about expanding MAVERIC Phase III trial network with the date April 28, 2026, and updated the 2026 stock prices on the page. Removed older stock price entries and an older press release about patent allowance dated November 13, 2025.SummaryDifference1%

- Check23 days agoChange DetectedUpdated displayed stock prices from $1.395 to $1.4201 and from $1.91 to $1.95 across the page.SummaryDifference0.5%

- Check30 days agoChange DetectedStock prices updated to $1.43 and $1.95; a new press release headline about MAVERIC/ARCHER added, and an older 2025 stock/press release item removed.SummaryDifference1%

- Check37 days agoChange DetectedThe two pricing blocks in the left sidebar were updated from $140 NASDAQ:CRDL and $1.95 TAXABLE to $1.29 NASDAQ:CRDL and $1.79 TAXABLE.SummaryDifference0.5%

Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.